Advanced Magnetics Sees Ferumoxytol NDA For Chronic Kidney Disease By Year End
This article was originally published in The Pink Sheet Daily
Executive Summary
The developer of nanotechnology-based therapeutics will require a 70-person sales force to promote ferumoxytol in the U.S., firm’s CEO tells “The Pink Sheet” DAILY.